Others had no significant changes, including KIAA1429, RBM15B, ZC3H13, CBLL1, ALKBH5, YTHDF1, YTHDF2, YTHDF3, IGF2BP1, and IGF2BP3 between NAFLD and control group. This evidence concerns the gene YTHDF3 and metabolic dysfunction-associated steatotic liver disease.